Specialty Overview

Best Hospitals for Thalassemia Surgery in Mumbai, India

17 hematology hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the hematology hospitals in our directory offering Thalassemia Surgery in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Ask us about thalassemia surgery in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Thalassemia Surgery in Mumbai, India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviews350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviews629 beds
Specialties & Accreditation
OncologyCancer Center
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviews500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviews638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviews326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviews350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationNABLNational Accreditation Board for Testing and Calibration Laboratories accreditation

Patients considering thalassemia surgery can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviews450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation

Patients considering thalassemia surgery can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviews310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviews300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering thalassemia surgery can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing thalassemia surgery.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location

Top Hematology Doctors in Mumbai, India

Image not available Featured

Dr. Muralidaran C

MBBS, MD, DM (Clinical Hematology)
Consultant Hematologist & Bone Marrow Transplant Physician · Specialty: Hematologist & BMT Specialist
Wockhardt Hospital Mumbai, India9+ Years experience
Why consider this doctor?
  • 9+ years of experience in Hematologist & BMT Specialist
  • Consultant Hematologist & Bone Marrow Transplant Physician, Wockhardt Hospital, Mumbai — Present
  • Superspecialty Medical Officer, MCGM–CTC PHO BMT Centre, Mumbai
Expertise & Procedures
  • Bone Marrow Aspiration and Biopsy
  • Autologous Stem Cell Transplantation (ASCT)
  • Allogeneic Bone Marrow Transplantation
  • Haploidentical BMT with Haploidentical Donors
  • Lymph Node Fine Needle Aspiration Cytology (FNAC)
View all procedures →
Hematologist & BMT Specialist Experience: 9+ YearsHospital Affiliation: Wockhardt HospitalHospital accreditation: NABH, NABL
Image not available

Dr. Vipin Khandelwal

MBBS, MD (Paediatrics), DM (Paediatric Oncology), PDF (Paediatric Haematology & BMT)
Consultant — Paediatric Haematology, Oncology & Bone Marrow Transplantation · Specialty: Paediatric Haematologist & BMT Specialist
Apollo Hospitals Navi Mumbai, India12+ Years experience
Why consider this doctor?
  • 12+ years of experience in Paediatric Haematologist & BMT Specialist
  • Consultant — Paediatric Haematology, Oncology & Bone Marrow Transplantation, Apollo Hospitals, Navi Mumbai
  • Advanced training in Paediatric Haematology and Bone Marrow Transplantation
Expertise & Procedures
  • Paediatric Bone Marrow Transplantation (BMT)
  • Haploidentical Stem Cell Transplantation
  • Matched Sibling Donor Transplant
  • Matched Unrelated Donor Transplant
  • Autologous Stem Cell Transplantation
View all procedures →
Paediatric Haematologist & BMT Specialist Experience: 12+ YearsHospital Affiliation: Apollo HospitalsHospital accreditation: JCI, NABH
Our Methodology

How we selected these hospitals

A hospital appears on this page when Hematology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Thalassemia Surgery in Mumbai, India?

Choosing the right hospital for thalassemia surgery is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include hematology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Thalassemia Surgery

Thalassaemia, a hereditary hemoglobinopathy causing chronic transfusion dependence and multi-organ iron overload, can be permanently cured through allogeneic Hematopoietic Stem Cell Transplantation (HSCT) — commonly known as Bone Marrow Transplant (BMT).

35–60 days (conditioning + transplant + acute engraftment monitoring in a laminar-airflow isolation unit)
Hospital Stay
4–6 months (immune reconstitution must be confirmed; international flight is typically cleared at Day +100 to Day +180 post-transplant, subject to treating physician clearance)
Total Stay in Country (Fit-to-Fly)
85–92% overall survival; 80–88% thalassaemia-free survival in Pesaro Class I–II patients at high-volume centers
Success Rate

Clinical Overview

  • Thalassaemia major (Cooley's anaemia) and thalassaemia intermedia are autosomal recessive disorders arising from mutations in the HBB gene (beta-thalassaemia) or HBA1/HBA2 genes (alpha-thalassaemia), resulting in deficient or absent globin chain synthesis.
  • The consequent ineffective erythropoiesis and peripheral haemolysis produce severe microcytic anaemia (haemoglobin 2–7 g/dL untreated), obligating patients to lifelong red cell transfusions every 2–4 weeks from infancy.
  • This transfusion burden generates progressive iron overload (serum ferritin often >2,500 ng/mL; liver iron concentration >7 mg Fe/g dry weight by MRI R2* quantification), leading to hepatic cirrhosis, cardiac siderosis (T2* cardiac MRI <10 ms indicating severe myocardial iron), endocrinopathies including hypogonadotropic hypogonadism, growth retardation, and hypothyroidism, as well as extramedullary haematopoiesis causing hepatosplenomegaly.
Full details →

Who is a Candidate?

  • CONFIRMED ELIGIBILITY:
  • Diagnosis of transfusion-dependent beta-thalassaemia major or severe thalassaemia intermedia confirmed by HPLC (High-Performance Liquid Chromatography), haemoglobin electrophoresis, and molecular mutation analysis (e.g., IVS1-5, IVS1-1, codon 41/42, codon 8/9 mutations)
  • Pesaro Class I or II status (preferred); selected Class III patients considered at specialized centers with RTC regimens
  • Age: Paediatric patients (2–16 years) have highest cure rates; adult transplant (up to 40 years) feasible at experienced centers with RTC or haploidentical protocols
  • +24 more

Treatment Options & Approaches

  • STANDARD MYELOABLATIVE CONDITIONING (MAC) — GOLD STANDARD FOR CLASS I–II PATIENTS:

Recovery

  • PHASE 1 — PRE-TRAVEL ASSESSMENT (Weeks -12 to -8 before transplant admission): GAF Healthcare coordinates remote case evaluation: medical records, mutation reports, HLA typing results, ferritin trends, organ function data, and existing chelation history are reviewed by the destination transplant team.
  • A formal eligibility report is issued within 5–7 working days.
  • Concurrently, HLA typing of all available family members is initiated or reviewed to identify the optimal donor category (MSD > MUD > Haploidentical).

Risks to be aware of

  • Allogeneic HSCT for thalassaemia carries meaningful procedural and long-term risks that patients must understand before proceeding.
  • Transplant-related mortality (TRM) ranges from 5–10% in Pesaro Class I–II matched sibling donor transplants at high-volume centers, rising to 15–25% in Class III or haploidentical settings.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a dedicated end-to-end non-medical coordination service for thalassaemia BMT patients traveling to India or the UAE, recognising that the 4–6 month total stay requires sustained logistical support far beyond what is needed for a standard surgical procedure.

Common questions about Thalassemia Surgery

What is the cost of Thalassaemia Curative Bone Marrow Transplant in India vs. the UAE?
The total cost of a curative allogeneic Bone Marrow Transplant (BMT) for thalassaemia varies significantly between the two destinations, driven by facility tier, donor type, conditioning regimen, and length of stay. In India, at NABH- and JCI-accredited transplant centers such as those in Chennai, Mumbai, Delhi NCR, or Hyderabad, the all-inclusive package cost for a Matched Sibling Donor (MSD) BMT — covering pre-transplant workup, conditioning medications (including IV Busulfan with TDM), stem cell collection, isolation room stay (35–60 days), standard post-transplant medications (CyA, MTX, anti-infectives, G-CSF), blood product support, and Day +100 chimerism testing — ranges from approximately USD 18,000 to USD 35,000. Haploidentical or Matched Unrelated Donor (MUD) transplants, which involve additional graft processing, extended ATG or PTCy protocols, and higher infection-risk monitoring costs, may reach USD 30,000–45,000. In the UAE, at JCI- and DHA/DOH-accredited centers such as Cleveland Clinic Abu Dhabi, Dubai Hospital, or Mediclinic City Hospital, equivalent MSD BMT programs are priced at USD 55,000 to USD 85,000, with MUD or haploidentical protocols reaching USD 80,000–100,000 or beyond, reflecting premium private room standards, higher staffing ratios, and operating cost structures. Neither estimate includes the cost of attendant accommodation, international airfare, or visa fees, all of which GAF Healthcare helps plan and optimize. India represents a 50–65% cost saving versus the UAE for equivalent clinical outcomes at high-volume centers.
How long do I need to stay in India or the UAE before I am safe to fly home after a thalassaemia bone marrow transplant?
This is one of the most critical planning questions for international patients, and the answer is substantially longer than for most other medical tourism procedures. Following stem cell infusion (Day 0), international air travel is not safe until a minimum of Day +100 post-transplant, and in many cases Day +120 to +180, subject to formal medical clearance by the transplant physician. The reasons are multifactorial: (1) Immune reconstitution is incomplete before Day +100 — the patient remains profoundly immunocompromised, with functional T-cell counts insufficient to handle respiratory pathogens encountered in a pressurized aircraft cabin. (2) Active immunosuppression (Ciclosporin A or Tacrolimus) must be at a stable therapeutic level with no active GvHD requiring dose escalation before travel. (3) Engraftment must be confirmed as full donor chimerism (>95%) and stable — mixed chimerism or declining chimerism at Day +100 requires local intervention before travel. (4) The patient must be independent of platelet transfusions (platelets >80×10⁹/L) and not requiring regular packed red cell transfusions, indicating stable graft function. (5) No active bacterial, fungal, or viral infection (particularly CMV or EBV viraemia) should be present. Practically, patients and their attendants should plan for a total in-country stay of 4 to 6 months. GAF Healthcare structures accommodation contracts accordingly and coordinates with the transplant team to issue a standardized fit-to-fly certificate for airline and immigration purposes at the appropriate milestone. Emergency repatriation protocols and letters for receiving-country emergency departments are provided to all patients at discharge.
What is the success rate of Bone Marrow Transplant for thalassaemia, and what factors affect it?
Overall survival (OS) and thalassaemia-free survival (TFS) — the two primary endpoints — vary with Pesaro Risk Class, donor type, patient age, and center experience. At high-volume Indian and UAE transplant centers, the following outcome benchmarks apply: Pesaro Class I (no hepatomegaly, no portal fibrosis, regular chelation history) with a Matched Sibling Donor: OS 90–95%, TFS 88–92%. Pesaro Class II (one or two risk factors) with MSD: OS 85–90%, TFS 80–88%. Pesaro Class III (all three risk factors: hepatomegaly, portal fibrosis, irregular chelation) with MSD: OS 70–80%, TFS 65–78% with modern Reduced-Toxicity Conditioning (Treosulfan-based regimens). Matched Unrelated Donor (MUD, 10/10 HLA match): OS 80–87%, TFS 75–83%. Haploidentical donor with Post-Transplant Cyclophosphamide (PTCy): OS 70–80%, TFS 68–76% at experienced centers. The most important modifiable pre-transplant factors improving outcomes are: (1) rigorous iron chelation reducing ferritin to <2,500 ng/mL and cardiac T2* to >10 ms before conditioning; (2) splenectomy in selected cases with massively enlarged spleens (>20 cm) causing hypersplenism and high transfusion demand, performed 6–8 weeks pre-transplant; (3) pharmacokinetic-guided IV Busulfan dosing, which reduces both under-exposure (leading to rejection) and over-exposure (leading to SOS/VOD and mucositis). Patients who achieve full donor chimerism at Day +30 and remain GvHD-free at Day +100 have an excellent long-term prognosis — approximately 85% are permanently cured and transfusion-independent at 5 years, never requiring another red cell transfusion for life.

How GAF Healthcare Assists in Choosing the Best Hospital for Thalassemia Surgery in Mumbai, India

Discover the Top Hospitals for Thalassemia Surgery in Mumbai, India

This page lists 17 accredited hematology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about thalassemia surgery in Mumbai, India

How many hematology hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for hematology including Thalassemia Surgery.
How do you choose which hospitals to list?
A hospital appears on this page when Hematology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there hematology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for thalassemia surgery?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about thalassemia surgery in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for thalassemia surgery in Mumbai, India.

Contact us to report an inaccuracy on this page.